FLT3 and acute myeloid leukemia: As expected, midostaurin notably most potently inhibits human AML cell lines, such as MV4‐11 and MOLM14, which express FLT3‐ITD, as compared to other human AML cell lines that express wt FLT3 and that are driven by other oncogenes (Figure 2A).